Charlotte’s Web Holdings asserts that more labelling cases against cannabinoid manufacturers should wait as federal administrators mull over ways of regulating hemp extracts.
The organization gave the statement last week in California’s federal court. It’s requesting a judge to adhere to the ruling of other state judges and snub cannabinoid labelling cases as premature.
Charlotte’s Web stated that federal administrators have high-ranking enforcement and regulatory authority in regards to marketing and labelling of cannabinoid products. This makes it inappropriate for a court to rule whether cannabinoid producers can label their goods as food supplements.
Charlotte’s Web’s defendant motion read that until the matter is tabled before Honorable Dolly Gee in California’s District Court, the case should be dismissed since the court doesn’t have authority over the claims. The court ruled that the plaintiff failed to demonstrate the exact instances constituting fraud. It also pointed out that the plaintiff failed to give a claim against the firm regarding which relief can be granted.
Law 360 was the first to report the filing.
More than four judges have rebuffed or delayed cannabinoid labelling lawsuits due to the stalled FDA (Foods and Drug Administration) action. This week, the federal department stated that it’ll continue reviewing the safety of OTC (over-the-counter) cannabinoids. However, it didn’t mention when it will release the regulations.
During August this year, a Massachusetts state judge gave a verdict that more lawsuits against cannabinoid markers regarding improper labelling will be postponed owing to the pending FDA regulations on the matter.
Judge Burroughs Allison said that she was allowing the defendant (Global Widget) to stay the case. She rejected their appeal to dissolve the case. The Florida-based firm, Global Widget, was accused of retailing cannabinoids with zero or low amounts of the claimed ingredients to offer any pharmacological benefit.
The lawsuit also read that America’s FDA hasn’t authorized cannabinoids for sale as dietary supplements.